Recent Finacing
Recent Raise
Freenome develops a multiomics blood test platform integrating cfDNA, methylation, transcriptomics, and proteomics with machine learning to detect early colorectal and other cancers and support clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Freenome.
